New Guidelines: HIV Exposure at Work, Treat ASAP

Healthcare workers exposed to HIV at work should immediately begin four weeks of post-exposure prophylaxis with three antiretroviral drugs, according to new recommendations.

The three-drug guideline is a change from the 2005 recommendations of the U.S. Public Health Service, which suggested prescribing the number of drugs based on an assessment of the risk of infection, according to David Kuhar, MD, of the CDC, and colleagues.

The new guidelines also suggest that the period of follow-up HIV testing can be shortened if newer fourth-generation assays are used, Kuhar and colleagues reported online and in the September issue of Infection Control and Hospital Epidemiology.

Michael Smith
North American Correspondent, MedPage Today
Read More

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below